Association between serum neurofilament light chain and periodontitis

被引:0
|
作者
Zhao, Jing [1 ]
Zhao, Panwen [1 ]
机构
[1] Nantong Univ, Affiliated Hosp 6, Dept Cent Lab, Yancheng Xindu Rd 606, Yancheng, Jiangsu, Peoples R China
关键词
Serum neurofilament light; Serum albumin; Periodontitis; Biomarker; Mediation analysis; ALBUMIN; DISEASE; INFLAMMATION; PREVALENCE; SCLEROSIS;
D O I
10.1007/s00784-024-05769-1
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives The association between serum neurofilament light chain (sNfL) and periodontitis remains unclear, and there is a need to examine the contribution of serum albumin (SA) in this association. The objective of the study is to investigate the correlation between sNfLand periodontitis, while examining the potential mediator role of SA in this association. Methods The study, which included 1218 participants from the 2013-2014 National Health and Nutrition Examination Survey (NHANES), aimed to evaluate the association between sNfL and periodontitis through weighted multivariable logistic regression analysis, restricted cubic spline (RCS) models, and stratified models. In addition, mediation analysis was used to investigate the role of SA in mediating this association. Results The multivariable logistic regression models revealed that sNfL was significantly linked to periodontitis (model 1: odds ratio [OR], 3.08, 95% confidence interval [CI], 1.48 to 6.39, model 2: OR, 3.69; 95% CI, 1.73 to 7.90, model 3: OR, 3.58, 95% CI, 1.52 to 8.43). The RCS models suggested a linear relationship between sNfL and periodontitis. The stratified analysis revealed no significant moderating effects (p-value > 0.05). The mediation analysis demonstrated that SA mediated the correlation between sNfL and periodontitis, with a mediation proportion of 10.62%. Conclusions The results point to sNfL being a factor in the heightened risk of periodontitis. Additionally, SA may mediate the changes in periodontitis that are associated with sNfL.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Association of ethylene oxide exposure with serum neurofilament light chain levels among American adults
    Yang, Xiuwen
    Feng, Huaili
    You, Ting
    Liu, Zhaoyi
    Sun, Fanwei
    Chen, Chengzhi
    Qiu, Jingfu
    FRONTIERS IN PUBLIC HEALTH, 2025, 13
  • [22] ASSOCIATION BETWEEN NEUROFILAMENT LIGHT CHAIN AND NEUROIMAGING CHANGES IN TREATMENT-RESISTANT SCHIZOPHRENIA
    Cilia, B.
    Eratne, D.
    Malpas, C. B.
    Diouf, I.
    Santillo, A.
    Janelidze, S.
    Hansson, O.
    Merritt, A.
    Syeda, W.
    Wannan, C.
    Pantelis, C.
    Velakoulis, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2022, 56 (1_SUPPL): : 55 - 56
  • [23] Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers
    Novobilsky, Richard
    Bartova, Petra
    Licha, Karin
    Bar, Michal
    Stejskal, David
    Kusnierova, Pavlina
    FRONTIERS IN HUMAN NEUROSCIENCE, 2023, 17
  • [24] Longitudinal measurement of serum neurofilament light chain in patients with CADASIL
    Choi, Jay Chol
    Kang, Ji-Hoon
    Lee, Jung-Seok
    CEREBROVASCULAR DISEASES, 2024, 53 : 122 - 122
  • [25] Serum neurofilament light chain is increased in hereditary spastic paraplegias
    Wilke, Carlo
    Rattay, Tim W.
    Hengel, Holger
    Zimmermann, Milan
    Brockmann, Kathrin
    Schoels, Ludger
    Kuhle, Jens
    Schuele, Rebecca
    Synofzik, Matthis
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2018, 5 (07): : 876 - 882
  • [26] Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy
    van Lieverloo, Gwen G. A.
    Wieske, Luuk
    Verhamme, Camiel
    Vrancken, Alexander F. J.
    van Doorn, Pieter A.
    Michalak, Zuzanna
    Barro, Christian
    van Schaik, Ivo N.
    Kuhle, Jens
    Eftimov, Filip
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2019, 24 (02) : 187 - 194
  • [27] Serum neurofilament light chain in patients with acute cerebrovascular events
    De Marchis, G. M.
    Katan, M.
    Barro, C.
    Fladt, J.
    Traenka, C.
    Seiffge, D. J.
    Hert, L.
    Gensicke, H.
    Disanto, G.
    Sutter, R.
    Peters, N.
    Sarikaya, H.
    Goeggel-Simonetti, B.
    El-Koussy, M.
    Engelter, S.
    Lyrer, P. A.
    Christ-Crain, M.
    Arnold, M.
    Kuhle, J.
    Bonati, L. H.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (03) : 562 - 568
  • [28] Serum neurofilament light chain in patients with amyotrophic lateral sclerosis
    Kawada, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 (11) : E65 - E65
  • [29] Enhancing the clinical value of serum neurofilament light chain measurement
    Kosa, Peter
    Masvekar, Ruturaj
    Komori, Mika
    Phillips, Jonathan
    Ramesh, Vighnesh
    Varosanec, Mihael
    Sandford, Mary
    Bielekova, Bibiana
    JCI INSIGHT, 2022, 7 (15)
  • [30] Serum neurofilament light chain in behavioral variant frontotemporal dementia
    Steinacker, Petra
    Anderl-Straub, Sarah
    Diehl-Schmid, Janine
    Semler, Elisa
    Uttner, Ingo
    von Arnim, Christine A. F.
    Barthel, Henryk
    Danek, Adrian
    Fassbender, Klaus
    Fliessbach, Klaus
    Foerstl, Hans
    Grimmer, Timo
    Huppertz, Hans-Jurgen
    Jahn, Holger
    Kassubek, Jan
    Kornhuber, Johannes
    Landwehrmeyer, Bernhard
    Lauer, Martin
    Maler, Juan Manuel
    Mayer, Benjamin
    Oeckl, Patrick
    Prudlo, Johannes
    Schneider, Anja
    Volk, Alexander E.
    Wiltfang, Jens
    Schroeter, Matthias L.
    Ludolph, Albert C.
    Otto, Markus
    NEUROLOGY, 2018, 91 (15) : E1390 - E1401